Reviva Pharmaceuticals announced that the Company will be added to the Russell Microcap Index, effective after the United States market opens on Monday, June 26, 2023, following the conclusion of the 2023 Russell indexes annual reconstitution.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on RVPH:
- Reviva Pharmaceuticals to be Added to Russell Microcap® Index
- Reviva Pharmaceuticals: Phase 3 RECOVER study 80% enrolled
- Reviva Pharmaceuticals Announces 80% Global Enrollment Update for Pivotal Phase 3 RECOVER Study Evaluating Brilaroxazine for Schizophrenia
- Reviva Pharmaceuticals to Present at Upcoming Investor Conferences in June
- Reviva Pharmaceuticals Announced Preclinical Efficacy Data on Brilaroxazine in IPF at the 2023 American Thoracic Society International Conference and Publication in Medical Research Archives